GlassScriptPhysician profile
John M Kavcic
NPI 1992708754
$27,066.92
in general payments reported to CMS, 2019-2025
67 companies · $4,306 in 2025
The $4,306 reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,714 · 2020: $2,960 · 2021: $4,074 · 2022: $4,151 · 2023: $4,373 · 2024: $3,489 · 2025: $4,306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Education: $11.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,156.40 |
| Education | $11.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $2,549.41 | 2022-2025 | Optimizer, Optimizer |
| Abbott Laboratories | $2,261.02 | 2019-2025 | Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $2,027.35 | 2019-2025 | Jardiance, Spiriva Respimat, Stiolto Respimat |
| Abbvie INC. | $1,849.08 | 2019-2025 | |
| Novo Nordisk INC | $1,751.19 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Lilly USA, LLC | $1,613.42 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $1,494.69 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Glaxosmithkline, LLC. | $1,474.51 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Amgen INC. | $1,426.68 | 2019-2025 | Repatha, Otezla, Otezla |
| Pfizer INC. | $1,311.86 | 2019-2025 | |
| Astellas Pharma US INC | $803.59 | 2019-2024 | Veozah, Myrbetriq |
| Merck Sharp & Dohme LLC | $725.66 | 2019-2025 | Verquvo, Gardasil 9, Belsomra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $623.38 | 2019-2025 | Xifaxan |
| Novartis Pharmaceuticals Corporation | $588.68 | 2019-2025 | |
| Exact Sciences Corporation | $532.70 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
Show all 67 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $527.21 | 2021-2025 | Korlym |
| Janssen Pharmaceuticals, INC | $518.71 | 2019-2022 | |
| Amarin Pharma, INC. | $496.71 | 2019-2023 | |
| Sanofi-Aventis U.S. LLC | $483.75 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $397.30 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $338.75 | 2019-2023 | Trintellix |
| Daiichi Sankyo INC. | $302.75 | 2019-2023 | Injectafer |
| Kowa Pharmaceuticals America, INC. | $250.21 | 2019-2023 | Seglentis, Livalo |
| E.R. Squibb & Sons, L.L.C. | $234.51 | 2019-2025 | Eliquis, Camzyos |
| Allergan, INC. | $226.13 | 2019-2020 | |
| Mannkind Corporation | $216.15 | 2021-2023 | Afrezza |
| Axsome Therapeutics, INC. | $144.88 | 2023-2025 | Auvelity |
| Esperion Therapeutics, INC. | $143.99 | 2020-2022 | |
| Grifols USA, LLC | $120.22 | 2019 | |
| Insulet Corporation | $117.39 | 2024-2025 | Omnipod |
| Currax Pharmaceuticals LLC | $115.44 | 2021-2023 | Contrave, Onzetra Xsail |
| Baxter Healthcare | $111.71 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Shield Therapeutics INC | $80.43 | 2023-2024 | Accrufer |
| Gilead Sciences, INC. | $73.88 | 2021-2023 | |
| Bausch Health US, LLC | $71.08 | 2020-2025 | Aplenzin |
| Idorsia Pharmaceuticals US INC | $64.92 | 2022-2023 | Quviviq |
| Biohaven Pharmaceuticals, INC. | $64.69 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $61.93 | 2022 | |
| Eisai INC. | $58.73 | 2019-2022 | |
| Paratek Pharmaceuticals, INC. | $51.40 | 2022-2024 | Nuzyra |
| Genentech USA, INC. | $47.53 | 2019 | |
| Boston Scientific Corporation | $44.50 | 2023-2025 | Watchman Access System, Watchman Flx |
| Vanda Pharmaceuticals INC. | $42.77 | 2019 | |
| Optinose US, INC. | $42.42 | 2021-2025 | |
| Scilex Pharmaceuticals INC. | $41.14 | 2019-2020 | |
| Inspire Medical Systems, INC. | $40.53 | 2024 | Inspire |
| Edwards Lifesciences Corporation | $37.04 | 2022-2024 | Sapien 3 Ultra Resilia |
| Amneal Pharmaceuticals LLC | $36.14 | 2023-2024 | Unithroid |
| Dermira, INC. | $34.61 | 2020 | |
| Dexcom, INC. | $32.68 | 2023-2024 | Dexcom G6 Transmitter |
| Ibsa Pharma INC. | $32.60 | 2024 | Licart, Tirosint, Flector |
| Ironwood Pharmaceuticals, INC | $31.20 | 2019-2020 | |
| Vbi Vaccine (Delaware) INC. | $28.33 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $26.87 | 2022 | |
| Biotronik INC. | $26.50 | 2023 | Acticor 7 Vr-T Dx, Edora 8 Dr-T |
| Sumitomo Pharma America, INC. | $24.53 | 2024 | Gemtesa |
| Impel Pharmaceuticals INC. | $24.00 | 2022 | |
| Seqirus USA INC | $23.57 | 2025 | Flucelvax, Fluad |
| Sanofi Pasteur INC. | $23.22 | 2022 | |
| Upsher-Smith Laboratories LLC | $17.95 | 2021 | |
| Sun Pharmaceutical Industries INC. | $16.46 | 2020 | |
| Phathom Pharmaceuticals, INC. | $16.32 | 2023 | Voquezna |
| Hikma Pharmaceuticals USA | $15.66 | 2023 | Ryaltris |
| Endo Pharmaceuticals INC. | $15.11 | 2019 | |
| Lundbeck LLC | $14.09 | 2025 | Rexulti |
| Amphastar Pharmaceuticals, INC. | $13.81 | 2024 | |
| Arbor Pharmaceuticals, INC. | $11.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Kavcic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.